𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A double-blind study to compare the efficacy, tolerance and safety of two doses of the angiotensin converting enzyme inhibitor ramipril with placebo

✍ Scribed by Alberto S. Villamil; Victoria Cairns; Peter U. Witte; Carlos A. Bertolasi


Book ID
113114201
Publisher
Elsevier Science
Year
1987
Tongue
English
Weight
505 KB
Volume
59
Category
Article
ISSN
0002-9149

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


A multicentre, randomized, double-blind,
✍ Bruno Dubois; Ian McKeith; Jean-Marc Orgogozo; Owen Collins; Didier Meulien πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 139 KB πŸ‘ 3 views

Background. Metrifonate is a long-lasting acetylcholinesterase inhibitor being developed for the symptomatic treatment of Alzheimer's disease (AD). Objectives. This study compared the ecacy, tolerability and safety of two doses of metrifonate in patients with mild-to-moderate AD, over a 26-week tre